Last reviewed · How we verify

NCT05802953

Quality of Life in Temporomandibular Joint Dysfunction

Status unknown Last updated 27 December 2023
What this trial tests

trial testing Physical assessments in Temporomandibular Joint Dysfunction Syndrome in 67 participants. Status unknown.

Timeline
2 November 2022
Primary endpoint
25 December 2023
25 December 2024

Quick facts

Lead sponsorAfyonkarahisar Health Sciences University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment67
Start date2 November 2022
Primary completion25 December 2023
Estimated completion25 December 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Afyonkarahisar Health Sciences University

Who can join

Adults 18 to 65, any sex, with Temporomandibular Joint Dysfunction Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is planned to examine the relationship between quality of life in patients with temporomandibular joint dysfunction and the patient's individual, physical and psychosocial characteristics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Temporomandibular Joint Dysfunction Syndrome

Currently open trials in the same condition.

Other Afyonkarahisar Health Sciences University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05802953.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing